KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Common Equity: 2009-2025

Historic Common Equity for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $51.0 billion.

  • Thermo Fisher Scientific's Common Equity rose 4.19% to $51.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $51.0 billion, marking a year-over-year increase of 4.19%. This contributed to the annual value of $49.6 billion for FY2024, which is 6.10% up from last year.
  • Thermo Fisher Scientific's Common Equity amounted to $51.0 billion in Q3 2025, which was up 1.01% from $50.5 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Common Equity's 5-year high stood at $51.0 billion during Q3 2025, with a 5-year trough of $35.1 billion in Q2 2021.
  • In the last 3 years, Thermo Fisher Scientific's Common Equity had a median value of $47.4 billion in 2024 and averaged $47.3 billion.
  • Data for Thermo Fisher Scientific's Common Equity shows a peak YoY climbed of 23.36% (in 2021) over the last 5 years.
  • Thermo Fisher Scientific's Common Equity (Quarterly) stood at $40.9 billion in 2021, then climbed by 7.78% to $44.0 billion in 2022, then climbed by 6.14% to $46.7 billion in 2023, then climbed by 6.10% to $49.6 billion in 2024, then rose by 4.19% to $51.0 billion in 2025.
  • Its Common Equity was $51.0 billion in Q3 2025, compared to $50.5 billion in Q2 2025 and $49.4 billion in Q1 2025.